The EPS projection of Hologic, Inc. (NASDAQ:HOLX) for quarter ended 2016-09-30 is $0.5. Last week, the EPS forecast was $0.5 against target of $0.5, a month earlier. Two months ago, this estimate was $0.5 versus forecast of $0.5 three months earlier, implying a deviation of 0%.
Hologic, Inc. (NASDAQ:HOLX) stated that 18 days ago, its stock price was positively revised 5 times while negative revisions were 0.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 1 , 4, 4, and 4, correspondingly.
EPS estimate downgrade for Hologic, Inc. (NASDAQ:HOLX) in the preceding 30, 120, 60 and 90 days were 0, 0, 0, and 0, correspondingly.
Hologic, Inc. (NASDAQ:HOLX) EPS target for the quarter closed 2 was $0.5, based on 11 recommendations. As reported on 2016-04-27 the EPS was $0.47. The change was $0.01, implying a percentage deviation of 2.17%. The projections showed a standard deviation of 0.01.
Quarterly Sales Estimates
Hologic, Inc. (NASDAQ:HOLX) yearly sales prediction for the fiscal 2017 stands at $763.995 and the median estimate is at $763.995. Almost 2 analysts issued sales target.
Highest sales target is $765.7 while the lowest target is $762.29 showing standard deviation of 2.411%.
As many as 2 analysts have sales targets revised upside while 2 reduced sales estimates, implying a deviation of -0.235%.
Last month, 2 revised sales number projection on upside while 2 lowered the sales projections, implying a deviation of -0.235%.
A quarter ago, 2 hiked sales target and 2 reduced sales forecast. Hologic, Inc. (NASDAQ:HOLX) announced that the deviation in forecast was -0.692%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...